about
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's...
Read More724.8K XNAS Volume
XNAS 14 May, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Allakos Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..